|
|
VisionSciences Inc Introduces New VideoBased Advanced Cystoscope and EndoSheath technology to...
prnewsnow.com May 11, 2008
(Emergency News and Information) VisionSciences Inc Nasdaq VSCI announced the international introduction of its video cystoscopy platform at the 23rd Annual European Association of Urology EAU conference in conjunction with the 9th International Meeting of Urological Nurses EAUN in Milan Italy...
Newstin has read and analyzed this article for you...
What is this article about?
- Investing & Markets,
- Health Care,
- Finance, Banking & Insurance,
- Patients,
- Urology,
- Stock Markets,
- Nursing,
- Nurses and Global Health,
- Financial Markets
Geography:
You might be also interested in the following articles found by Newstin:
Global warming may increase kidney stones
upi.com 5 hrs ago 2 related
DALLAS, May 21 (UPI) -- U.S. urologists say rising global temperatures might lead to an increase in kidney stones. The study, presented Tuesday in Orlando, Fla., during the 103rd Annual Scientific Meeting of the American Urological Association, shows kidney stone disease, already linked with...
Experts from 10 countries develop first evidence-based definition of lifelong premature ejaculation
physorg.com 5 hrs ago 2 related
International experts from ten countries have teamed up to develop the first ever evidence-based definition of lifelong premature ejaculation (PE) in the hope that it will aid future diagnosis, treatment and research. The results of their in-depth study, conducted by the Standards Committee of...
Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic...
yahoo.com 5 hrs ago 1 related
Wednesday May 21, 9:00 am ET - Innovative pipeline products highlight Watson's commitment to urology - The abstracts include a cardiac safety trial involving silodosin, an investigational treatment for benign prostatic hyperplasia (BPH, or prostate enlargement) and a pharmacokinetic study of...
Streetinvesting.com: Market Review on Cell Genesys, Inc.
tmcnet.com 8 hrs ago 16 related
Streetinvesting.com has now resumed our progressive Cell Genesys, Inc. (NASDAQ:CEGE) as it opened up $0.12 on below average volume early trading Wednesday, May 21, 2008. Cell Genesys, Inc. reported encouraging interim data from the expansion cohort of the Phase 1, multicenter clinical trial of...